Terms: = Bone cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
23 results:
1. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.
Zhu Q; Zhang X; Lu F; Miao S; Zhang C; Liu Z; Gao Z; Qi M; An X; Geng P; Wang S; Ren H; Han F; Zhang R; Zha D
Cell Commun Signal; 2024 Apr; 22(1):227. PubMed ID: 38610001
[TBL] [Abstract] [Full Text] [Related]
2. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
3. Eosinophils in the pathogenesis of pancreatic disorders.
Manohar M; Kandikattu HK; Upparahalli Venkateshaiah S; Yadavalli CS; Mishra A
Semin Immunopathol; 2021 Jun; 43(3):411-422. PubMed ID: 33783592
[TBL] [Abstract] [Full Text] [Related]
4. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Vashum Y; Premsingh R; Kottaiswamy A; Soma M; Padmanaban A; Kalaiselvan P; Samuel S
Mol Biol Rep; 2021 Jan; 48(1):105-116. PubMed ID: 33294960
[TBL] [Abstract] [Full Text] [Related]
5. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
6. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract] [Full Text] [Related]
7. Serum markers in early-stage and locally advanced melanoma.
Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
[TBL] [Abstract] [Full Text] [Related]
8. Progress in detecting cell-surface protein receptors: the erythropoietin receptor example.
Elliott S; Sinclair A; Collins H; Rice L; Jelkmann W
Ann Hematol; 2014 Feb; 93(2):181-92. PubMed ID: 24337485
[TBL] [Abstract] [Full Text] [Related]
9. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract] [Full Text] [Related]
10. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
[TBL] [Abstract] [Full Text] [Related]
11. Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, timp-1 and timp-2 in angiocentric midfacial lymphomas.
Meneses-García A; Betancourt AM; Abarca JH; Montes AB; Roa LS; Ruíz-Godoy L
World J Surg Oncol; 2008 Oct; 6():114. PubMed ID: 18954439
[TBL] [Abstract] [Full Text] [Related]
12. Preclinical investigations with epothilones in breast cancer models.
Burris HA
Semin Oncol; 2008 Apr; 35(2 Suppl 2):S15-21; quiz S39. PubMed ID: 18410795
[TBL] [Abstract] [Full Text] [Related]
13. Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.
Maeda T; Hashitani S; Zushi Y; Segawa E; Tanaka N; Sakurai K; Urade M
J Cancer Res Clin Oncol; 2008 Sep; 134(9):1005-11. PubMed ID: 18317806
[TBL] [Abstract] [Full Text] [Related]
14. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract] [Full Text] [Related]
15. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
Dempke W
Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
[TBL] [Abstract] [Full Text] [Related]
17. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract] [Full Text] [Related]
18. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (timp-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
[TBL] [Abstract] [Full Text] [Related]
19. Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and timps.
Sugita H; Osaka S; Toriyama M; Osaka E; Yoshida Y; Ryu J; Sano M; Sugitani M; Nemoto N
Anticancer Res; 2004; 24(6):4079-84. PubMed ID: 15736455
[TBL] [Abstract] [Full Text] [Related]
20. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract] [Full Text] [Related]
[Next]
